These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 36472194)

  • 21. Pericardial effusion requiring intervention in patients undergoing percutaneous left atrial appendage occlusion: Prevalence, predictors, and associated in-hospital adverse events from 17,700 procedures in the United States.
    Munir MB; Khan MZ; Darden D; Pasupula DK; Balla S; Han FT; Reeves R; Hsu JC
    Heart Rhythm; 2021 Sep; 18(9):1508-1515. PubMed ID: 34020049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety profiles of percutaneous left atrial appendage closure devices: An analysis of the Food and Drug Administration Manufacturer and User Facility Device Experience (MAUDE) database from 2009 to 2016.
    Jazayeri MA; Vuddanda V; Turagam MK; Parikh V; Lavu M; Atkins D; Earnest M; Di Biase L; Natale A; Wilber D; Reddy YM; Lakkireddy DR
    J Cardiovasc Electrophysiol; 2018 Jan; 29(1):5-13. PubMed ID: 28988455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of the Amplatzer Amulet and Watchman 2.5 for left atrial appendage occlusion: A systematic review and meta-analysis.
    Zhu MZ; Song H; Song GM; Bai X
    Pacing Clin Electrophysiol; 2022 Oct; 45(10):1237-1247. PubMed ID: 35933600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short term outcome after left atrial appendage occlusion with the AMPLATZER Amulet and WATCHMAN device: results from the ORIGINAL registry (saxOnian RegIstry analyzinG and followINg left atrial Appendage cLosure).
    Kretzler L; Mues C; Wunderlich C; Langbein A; Spitzer SG; Gerk U; Schellong S; Ketteler T; Neuser H; Schwefer M; Strasser R; Ibrahim K; Schoen S; Christoph M
    BMC Cardiovasc Disord; 2022 Jun; 22(1):271. PubMed ID: 35710343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracardiac vs Transesophageal Echocardiography for Left Atrial Appendage Occlusion With Watchman FLX in the U.S.
    Ferro EG; Alkhouli M; Nair DG; Kapadia SR; Hsu JC; Gibson DN; Freeman JV; Price MJ; Roy K; Allocco DJ; Yeh RW; Piccini JP
    JACC Clin Electrophysiol; 2023 Dec; 9(12):2587-2599. PubMed ID: 37831030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Device Sizing Guided by Echocardiography-Based Three-Dimensional Printing Is Associated with Superior Outcome after Percutaneous Left Atrial Appendage Occlusion.
    Fan Y; Yang F; Cheung GS; Chan AK; Wang DD; Lam YY; Chow MC; Leong MC; Kam KK; So KC; Tse G; Qiao Z; He B; Kwok KW; Lee AP
    J Am Soc Echocardiogr; 2019 Jun; 32(6):708-719.e1. PubMed ID: 30948144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Percutaneous left atrial appendage occlusion in mitral valve disease: A Nationwide Readmission Database analysis.
    Feroze R; Ullah W; Kang P; Lobo T; Alhabdan N; Alghammass M; Yoon SH; Dallan LAP; Filby SJ
    Cardiovasc Revasc Med; 2024 Jun; 63():23-30. PubMed ID: 38267285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Procedural and Short-Term Results With the New Watchman FLX Left Atrial Appendage Occlusion Device.
    Cruz-González I; Korsholm K; Trejo-Velasco B; Thambo JB; Mazzone P; Rioufol G; Grygier M; Möbius-Winkler S; Betts T; Meincke F; Sandri M; Schmidt B; Schmitz T; Nielsen-Kudsk JE
    JACC Cardiovasc Interv; 2020 Dec; 13(23):2732-2741. PubMed ID: 33189641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Left Atrial Appendage Occlusion Using Cardiac CT Angiography and Intracardiac Echocardiography: A Prospective, Single-Center Study.
    Filby SJ; Dallan LAP; Cochet A; Kobayashi A; Attizzani GF; Rashid I; Rajagopalan S; Arruda M; Shishehbor MH; Bezerra HG
    J Invasive Cardiol; 2021 Nov; 33(11):E851-E856. PubMed ID: 34619655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feasibility of left atrial appendage device closure following chronically failed surgical ligation.
    Ellis CR; Metawee M; Piana RN; Bennett JM; Pretorius M; Deegan RJ
    Heart Rhythm; 2019 Jan; 16(1):12-17. PubMed ID: 30012348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Temporal changes and clinical significance of peridevice leak following left atrial appendage occlusion with Amplatzer devices.
    Korsholm K; Jensen JM; Nørgaard BL; Nielsen-Kudsk JE
    Catheter Cardiovasc Interv; 2022 Jun; 99(7):2071-2079. PubMed ID: 35582829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intracardiac Versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion: The LAAO Italian Multicenter Registry.
    Berti S; Pastormerlo LE; Santoro G; Brscic E; Montorfano M; Vignali L; Danna P; Tondo C; Rezzaghi M; D'Amico G; Stabile A; Saccà S; Patti G; Rapacciuolo A; Poli A; Golino P; Magnavacchi P; Meucci F; Pezzulich B; Stolcova M; Tarantini G
    JACC Cardiovasc Interv; 2018 Jun; 11(11):1086-1092. PubMed ID: 29880104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amplatzer Amulet™ left atrial appendage occluder: A step-by-step guide to device implantation.
    Ellis CR
    J Cardiovasc Electrophysiol; 2022 Aug; 33(8):1881-1887. PubMed ID: 35175683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peridevice Leak After Transcatheter Left Atrial Appendage Occlusion: An Analysis of the Amulet IDE Trial.
    Price MJ; Ellis CR; Nielsen-Kudsk JE; Thaler D; Gupta N; Koulogiannis K; Anderson JA; Gage R; Lakkireddy D
    JACC Cardiovasc Interv; 2022 Nov; 15(21):2127-2138. PubMed ID: 36357016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Real-world experience with the new Watchman FLX device: Data from two high-volume Sicilian centers. The FLX-iEST registry.
    Vizzari G; Grasso C; Sardone A; Mazzone P; Laterra G; Frazzetto M; Sacchetta G; Micari A; Tamburino C; Contarini M
    Catheter Cardiovasc Interv; 2022 Jul; 100(1):154-160. PubMed ID: 35592941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcatheter embolic coils to treat peridevice leaks after left atrial appendage closure.
    Musikantow DR; Shivamurthy P; Croft LB; Kawamura I; Turagam MK; Whang W; Dukkipati SR; Goldman ME; Reddy VY
    Heart Rhythm; 2021 May; 18(5):717-722. PubMed ID: 33549807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Watchman device migration and embolization: A report from the NCDR LAAO Registry.
    Friedman DJ; Freeman JV; Zimmerman S; Tan Z; Pereira L; Faridi KF; Curtis JP
    J Cardiovasc Electrophysiol; 2023 May; 34(5):1192-1195. PubMed ID: 37078339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delayed endothelialization of watchman device identified with cardiac CT.
    Sivasambu B; Arbab-Zadeh A; Hays A; Calkins H; Berger RD
    J Cardiovasc Electrophysiol; 2019 Aug; 30(8):1319-1324. PubMed ID: 31257658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bleeding Outcomes After Left Atrial Appendage Closure Compared With Long-Term Warfarin: A Pooled, Patient-Level Analysis of the WATCHMAN Randomized Trial Experience.
    Price MJ; Reddy VY; Valderrábano M; Halperin JL; Gibson DN; Gordon N; Huber KC; Holmes DR
    JACC Cardiovasc Interv; 2015 Dec; 8(15):1925-1932. PubMed ID: 26627989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frailty and associated outcomes in patients undergoing percutaneous left atrial appendage occlusion: findings from the NCDR LAAO registry.
    Darden D; Bilal Munir M; Zimmerman S; Eskander M; Pothineni NVK; Gopinathannair R; Kabra R; Lakkireddy D; Duong T; Han FT; Freeman JV; Hsu JC
    J Interv Card Electrophysiol; 2024 Apr; 67(3):625-635. PubMed ID: 37858000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.